What is the common examiner trap about Intl. Relations in UPSC exams?

The trap will be to confuse 'ad valorem tariff' with 'specific tariff' or to think all pharmaceuticals are exempt. The exemption applies only to certain specialty drugs (rare diseases, infertility, cell/gene therapies, ADCs, animal pharma) and not to all patented drugs.

What should UPSC aspirants remember about Intl. Relations for Prelims?

1. Target this Data: 100% tariff on patented pharmaceuticals, 20 exempted countries, zero tariff for certain specialty drugs. 2. Target this Nodal Body: U.S. Commerce Department (publishes list in Federal Register). 3. Target this Legal Point: Section 232 of the Trade Expansion Act (basis for tariff).

International RelationsEconomy

Take AI Challenge ▸

News 0 of 26

U.S. Enforces 100% Pharma Tariff, Exempts Rare-Disease Drugs from India & 19 Others

Q: The recent U.S. tariff on pharmaceutical imports is based on which statutory provision?

Trade Expansion Act of 1962, The article explicitly mentions that the tariff is imposed under Section 232 of the Trade Expansion Act. Section 232 allows the President to restrict imports for national security reasons.

Q: Consider the following statements regarding the U.S. pharmaceutical tariff: 1. The 100% tariff applies to all patented pharmaceuticals and their associated ingredients. 2. All specialty drugs are exempted from the tariff. 3. Generic pharmaceutical products are not subject to the Section 232 tariffs. Which of the statements given above is/are correct?

Both 1 and 3, Statement 1 is correct because the proclamation imposes 100% tariff on patented pharmaceuticals and their associated ingredients. Statement 2 is incorrect as only certain specialty drugs (for rare diseases, infertility, etc.) are exempt, not all specialty drugs. Statement 3 is correct as the article states generic products are not subject to Section 232 tariffs.

Q: How many countries, including India, are exempt from the U.S. tariff on specialty drugs?

20, The article clearly states that the U.S. will not charge tariffs on certain specialty drugs from India and 19 other countries, making a total of 20 countries.

Q: What is the primary objective of the U.S. imposing a 100% tariff on patented pharmaceuticals?

To encourage domestic production of pharmaceuticals, The article mentions the tariff is part of efforts to encourage domestic production. The proclamation aimed to boost U.S. manufacturing of drugs and reduce reliance on imports, aligning with protectionist trade policies.

Intl. Relations EconomyHIGH

Target:UPSC GS-IIMPSCSSC GATeachingPrelims HighMains MediumStatic GK Link

29 Sept 2026

~2 min

Source: The Hindu

Key Data:100% tariff20 countrieszero per cent tariffSection 232September 29Trade Expansion Act

Bodies:U.S. Commerce DepartmentWorld Customs OrganisationU.S. President

Practice MCQs from today's news ▸

~2 min · Quick mode

What This Article Covers

1.The U.S. will not charge ad valorem tariffs on specific specialty drugs and components from India and 19 other countries, despite a broader 100% tariff on patented pharma.

2.The exemption applies to drugs for rare diseases, infertility, cell/gene therapies, antibody-drug conjugates, and animal pharma, as these countries have trade/security agreements with the U.S.

3.The move is part of President Trump's April 2 proclamation under Section 232 of the Trade Expansion Act, aimed at encouraging domestic pharmaceutical production.

The Big Picture

Prelims · HighMains · Medium

The U.S. is imposing a 100% tariff on patented pharmaceuticals to boost domestic production, but exempts certain specialty drugs—including those for rare diseases and infertility—from 20 countries, including India. This impacts India's pharma exports and highlights the strategic use of Section 232 tariffs.

Exam Lens

Quick Exam Facts From News

Tariff Rate100% on patented pharmaceuticals

Exempted Specialty DrugsRare disease, infertility, cell/gene therapies, ADCs, animal pharma – 0% tariff

Number of Exempted Countries20 (including India)

Legal BasisSection 232 of the Trade Expansion Act

Effective DatesJuly 31 (named companies), September 29 (all covered companies)

1-Minute Revision

›Tariff Rate: 100% on patented pharmaceuticals
›Exempted Specialty Drugs: Rare disease, infertility, cell/gene therapies, ADCs, animal pharma – 0% tariff
›Target this Data: 100% tariff on patented pharmaceuticals, 20 exempted countries, zero tariff for certain specialty drugs.
›Target this Nodal Body: U.S. Commerce Department (publishes list in Federal Register).
›Target this Legal Point: Section 232 of the Trade Expansion Act (basis for tariff).

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

News Snapshot

🏥

Rare Disease Drugs Exempt

Specialty drugs for rare diseases, infertility, cell/gene therapies, ADCs, and animal pharma get zero tariff.

🌍

20 Countries Covered

India, EU, Japan, South Korea, and others avoid 100% tariff due to trade/security agreements with the U.S.

⚖️

Section 232 Authority

The tariff is imposed under Section 232 of the Trade Expansion Act, citing national security.

Detailed Analysis & Strategic Depth

Context / Background

The U.S. government, under President Trump, issued a proclamation on April 2 to impose 100% tariffs on patented pharmaceuticals and their ingredients. This is part of a broader push to move pharmaceutical manufacturing back to American soil. The Commerce Department published the list of countries in the Federal Register, indicating which nations qualify for exemptions based on existing or forthcoming trade and security framework agreements.

Core Analysis & Implications

The exemption of 20 countries, including India, ensures that specialty drugs for rare diseases, infertility treatments, cell therapies, gene therapies, antibody-drug conjugates (ADCs), and animal pharmaceuticals remain tariff-free. This reduces cost burdens for U.S. patients and maintains access to critical medicines. However, the 100% tariff on patented drugs could raise prices for other medications, potentially affecting global supply chains and India's pharmaceutical exports.

Future Outlook / Way Forward

The tariff is effective from July 31 for named companies and September 29 for all covered companies. Technical corrections were made, including defining 'generic pharmaceutical articles' to include unpatented animal health products, and clarifying that 'pharmaceutical articles' cover finished products, active ingredients, and key starting materials. These definitions will influence how the tariffs are applied and may lead to further legal challenges or diplomatic negotiations.

Key Facts at a Glance

Tariff Rate100% on patented pharmaceuticals

Exempted Specialty DrugsRare disease, infertility, cell/gene therapies, ADCs, animal pharma – 0% tariff

Number of Exempted Countries20 (including India)

Legal BasisSection 232 of the Trade Expansion Act

Effective DatesJuly 31 (named companies), September 29 (all covered companies)

You've read the full analysis. Now test your understanding.

Practice exam-style questions based on this article.

Q1Static LinkageEasyUPSC, SSC, Banking

The recent U.S. tariff on pharmaceutical imports is based on which statutory provision?

Q2Statement-basedHardUPSC, SSC

Consider the following statements regarding the U.S. pharmaceutical tariff:

1. The 100% tariff applies to all patented pharmaceuticals and their associated ingredients.

2. All specialty drugs are exempted from the tariff.

3. Generic pharmaceutical products are not subject to the Section 232 tariffs.

Which of the statements given above is/are correct?

Q3Data-centricEasyUPSC, SSC, Banking

How many countries, including India, are exempt from the U.S. tariff on specialty drugs?

Q4Application/ImpactMediumUPSC, Banking, SSC

What is the primary objective of the U.S. imposing a 100% tariff on patented pharmaceuticals?

All 15 MCQs ▸

Read original article from The Hindu

You finished this topic

Practice 3 MCQs from this news Next Article

Explore Related Topics

Intl. RelationsView Topic MCQs →EconomyView Topic MCQs →

Next SC Collegium Recommends 3 HC CJs for Elevation; Manipur Naga-Kuki Violence Escalates; India Unveils PRAHAAR Counter-Terror Policy

Related Current Affairs

Intl. Relations Current Affairs

US Imposes 100% Tariff on India Pharma Exports from 2028, Impact on $150 Bn Trade

Trump's unilateral tariff actions on Indian pharmaceutical exports (100% from 2028, rising to 200%) and use of Sections 301, 232, and 338 expose the fragility of ongoing India-US trade negotiations. Despite $150 billion bilateral trade and India's surplus, no signed agreement seems safe. India should prioritize trade diversification towards the UK and EU.

Economy Current Affairs

India-U.S. Trade Pact: Exporters Urge Early Conclusion, Tariff Uncertainty Hits Orders, Trade Surplus Narrows to $33.9 Bn

The Commerce Ministry met exporters to discuss India-U.S. trade performance and market access issues amidst ongoing bilateral trade agreement (BTA) negotiations. Exporters urged early conclusion of the pact to reduce tariff uncertainties, as U.S. buyers have reduced order volumes. The meeting also flagged concerns over U.S. safeguard measures on quartz surface products.

Economy Current Affairs

India Achieves Tariff Parity on Textile Exports with Bangladesh, Vietnam; Nine FTAs Cover $60 Trillion GDP

India's textile industry can no longer blame tariffs for poor export performance as Commerce Minister Piyush Goyal announced that India now enjoys tariff parity or advantage over competitors like Bangladesh and Vietnam in most developed markets, thanks to an expanding network of FTAs covering $60 trillion GDP.

Economy Current Affairs

Russia Accounts for 51% of India's Oil Imports in July 2026; US House Passes 100% Tariff Bill

India's reliance on Russian oil hit a record high of 51% in July 2026, even as the US House passed a bill to impose 100% tariffs on countries importing Russian oil. This poses a strategic dilemma for India's energy security and foreign policy.

Economy Current Affairs

US Sanctioning Act: 100% Tariff on India's Russian Oil Imports

The U.S. has enacted the Lindsey O. Graham Sanctioning Russia and Iran Act, 2026, which imposes a 100% tariff on goods from countries that continue to import Russian oil. India, a top importer, faces a strategic dilemma between its energy security needs and potential trade losses.

Intl. Relations Current Affairs

US Waives 100% Tariff on Select Indian Speciality Drugs; 20 Nations Eligible

The US has waived 100% tariff on select speciality drugs from India and 19 other nations, benefiting Indian generic drug exports. The move is under Section 232 of the Trade Expansion Act and aims to address US health needs while encouraging domestic production.

Intl. Relations Current Affairs

India, New Zealand Sign FTA: Key Tariff Cuts on Dairy, Pharma & Trade Pact Details

India and New Zealand have signed a Free Trade Agreement (FTA) aimed at boosting bilateral trade. This editorial analyzes the strategic timing, sectoral impacts (dairy, pharma, services), and the geopolitical context of the deal, which is crucial for understanding India's evolving trade policy and its implications for domestic industries.

Economy Current Affairs

Russia's Share in India's Oil Imports Hits 48% as U.S. Senate Passes 100% Tariff Bill

India’s dependence on Russian oil has hit a record 48% of total crude imports in June 2026, even as the U.S. Senate passed a bill to impose up to 100% tariffs on top buyers of Russian oil. This creates a strategic dilemma for India—balancing energy security with potential U.S. sanctions exposure—making it a high-priority topic for Economy and IR questions in exams.

Start Today's Quiz(15 Qs)

Take Today's Quiz

15 Qs • 5-7 Mins

U.S. Enforces 100% Pharma Tariff, Exempts Rare-Disease Drugs from India & 19 Others

Exam Lens

Quick Exam Facts From News

1-Minute Revision

News Snapshot

Rare Disease Drugs Exempt

20 Countries Covered

Section 232 Authority

Detailed Analysis & Strategic Depth

Context / Background

Core Analysis & Implications

Future Outlook / Way Forward

Prelims Flashpoints

Key Facts at a Glance